<i>APOE</i> ε4 alters associations between docosahexaenoic acid and preclinical markers of Alzheimer’s disease

Brain Communications - Tập 3 Số 2 - 2021
Gillian Coughlan1,2, Ryan Larsen3, Min Kim4, David White5, Rachel Gillings1, Michael A. Irvine1, Andrew Scholey5, Neal J. Cohen3, Cristina Legido‐Quigley4, Michael Hornberger1, Anne Marie Minihane1
1Norwich Medical School, University of East Anglia, Norwich, UK
2Rotman Research Institute, Baycrest, Toronto, ON, Canada
3Decision Neuroscience Laboratory, Beckman Institute for Advanced Science and Technology, University of Illinois, USA
4King's College London, Franklin-Wilkins Building, London, UK
5Centre for Human Psychopharmacology, Swinburne University, Australia

Tóm tắt

Abstract Docosahexaenoic acid is the main long-chain omega-3 polyunsaturated fatty acids in the brain and accounts for 30−40% of fatty acids in the grey matter of the human cortex. Although the influence of docosahexaenoic acid on memory function is widely researched, its association with brain volumes is under investigated and its association with spatial navigation is virtually unknown. This is despite the fact that spatial navigation deficits are a new cognitive fingerprint for symptomatic and asymptomatic Alzheimer’s disease. We investigated the cross-sectional relationship between docosahexaenoic acid levels and the major structural and cognitive markers of preclinical Alzheimer’s disease, namely hippocampal volume, entorhinal volume and spatial navigation ability. Fifty-three cognitively normal adults underwent volumetric magnetic resonance imaging, measurements of serum docosahexaenoic acid (DHA, including lysophosphatidylcholine DHA) and APOE ε4 genotyping. Relative regional brain volumes were calculated and linear regression models were fitted to examine DHA associations with brain volume. APOE genotype modulated serum DHA associations with entorhinal cortex volume and hippocampal volume. Linear models showed that greater serum DHA was associated with increased entorhinal cortex volume, but not hippocampal volume, in non APOΕ ε4 carriers. APOE also interacted with serum lysophosphatidylcholine DHA to predict hippocampal volume. After testing interactions between DHA and APOE on brain volume, we investigated whether DHA and APOE interact to predict spatial navigation performance on a novel virtual reality diagnostic test for Alzheimer’s disease in an independent population of APOE genotyped adults (n = 46). APOE genotype modulated DHA associations with spatial navigation performance, showing that DHA was inversely associated with path integration in APOE ε4 carriers only. This exploratory analysis suggests that interventions aiming to increase DHA blood levels to protect against cognitive decline should consider APOE ε4 carrier status. Future work should focus on replicating our initial findings and establishing whether a specific dose of supplementary DHA, at a particular time in the preclinical disease course can have a positive impact on Alzheimer’s disease progression in APOE ε4 carriers.

Từ khóa


Tài liệu tham khảo

Larson, 2013, New insights into the dementia epidemic, N Engl J Med, 369, 2275, 10.1056/NEJMp1311405

Vauzour, 2017, Nutrition for the ageing brain: Towards evidence for an optimal diet, Ageing Res Rev, 35, 222, 10.1016/j.arr.2016.09.010

Lewis, 2014

Lim, 2006, Omega 3 fatty acid for the prevention of dementia, Cochrane Database Syst Rev, 1, CD005379

Ammann, 2017, Erythrocyte omega-3 fatty acids are inversely associated with incident dementia: Secondary analyses of longitudinal data from the Women’s Health Initiative Memory Study (WHIMS), Prostaglandins Leukot Essent Fat Acids, 121, 68, 10.1016/j.plefa.2017.06.006

He, 2009, Improved spatial learning performance of fat-1 mice is associated with enhanced neurogenesis and neuritogenesis by docosahexaenoic acid, Proc Natl Acad Sci U S A, 106, 11370, 10.1073/pnas.0904835106

Yassine, 2016, Association of serum docosahexaenoic acid with cerebral amyloidosis, JAMA Neurol, 73, 1208, 10.1001/jamaneurol.2016.1924

Coughlan, 2018, Spatial navigation deficits — Overlooked cognitive marker for preclinical Alzheimer disease?, Nat Rev Neurol, 14, 496, 10.1038/s41582-018-0031-x

Tu, 2015, Lost in spatial translation - A novel tool to objectively assess spatial disorientation in Alzheimer’s disease and frontotemporal dementia, Cortex, 67, 83, 10.1016/j.cortex.2015.03.016

Lester, 2017, The aging navigational system, Neuron, 95, 1019, 10.1016/j.neuron.2017.06.037

Lacombe, 2018, Brain docosahexaenoic acid uptake and metabolism, Mol Aspects Med, 64, 109, 10.1016/j.mam.2017.12.004

Pottala, 2014, Higher RBC EPA 1 DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI Study, Neurology, 82, 435, 10.1212/WNL.0000000000000080

Arsenault, 2011, DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD mice, PLoS One, 6, e17397, 10.1371/journal.pone.0017397

Oksman, 2006, Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice, Neurobiol Disord, 23, 563, 10.1016/j.nbd.2006.04.013

Fedorova, 2007, An n-3 fatty acid deficient diet affects mouse spatial learning in the Barnes circular maze, Prostaglandins Leukot Essent Fat Acids, 77, 269, 10.1016/j.plefa.2007.10.013

Lim, 2005, N-3 fatty acid deficiency induced by a modified artificial rearing method leads to poorer performance in spatial learning tasks, Pediatr Res, 58, 741, 10.1203/01.PDR.0000180547.46725.CC

Schaefer, 2006, Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: The Framingham heart study, Arch Neurol, 63, 1545, 10.1001/archneur.63.11.1545

Devore, 2009, Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk, Am J Clin Nutr, 90, 170, 10.3945/ajcn.2008.27037

Tomaszewski, 2020, Effect of APOE genotype on plasma docosahexaenoic acid (DHA), eicosapentaenoic acid, arachidonic acid, and hippocampal volume in the Alzheimer’s disease cooperative study-sponsored DHA clinical trial, J Alzheimer’s Dis, 74, 975, 10.3233/JAD-191017

Chouinard-Watkins, 2014, Fatty acid metabolism in carriers of apolipoprotein e epsilon 4 allele: Is it contributing to higher risk of cognitive decline and coronary heart disease?, Nutrients, 6, 4452, 10.3390/nu6104452

Yassine, 2017, Association of docosahexaenoic acid supplementation with Alzheimer disease stage in apolipoprotein E ε4 carriers: A review, JAMA Neurol, 74, 339, 10.1001/jamaneurol.2016.4899

Zamroziewicz, 2015, Anterior cingulate cortex mediates the relationship between O3PUFAs and executive functions in APOE e4 carriers, Front Aging Neurosci, 7, 1, 10.3389/fnagi.2015.00087

Corder, 1993, Gene dose of apolipoprotein E type 4 allele gene dose of apolipoprotein and the risk of Alzheimer’s disease in late onset families, Science, 261, 921, 10.1126/science.8346443

Montagne, 2020, APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline, Nature, 581, 71, 10.1038/s41586-020-2247-3

Vandal, 2014, Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2, J Neurochem, 129, 516, 10.1111/jnc.12640

Irvine, 2018, The cognitive ageing, nutrition and neurogenesis (CANN) trial: Design and progress, Alzheimer’s Dement Transl Res Clin Interv, 4, 591, 10.1016/j.trci.2018.08.001

Nasreddine, 2005, The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment, Water Resour Res, 53, 695

Liu, 2013, Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy, Nat Rev Neurol, 9, 106, 10.1038/nrneurol.2012.263

Coughlan, 2019, Toward personalized cognitive diagnostics of at-genetic-risk Alzheimer’s disease, Proc Natl Acad Sci, 116, 9285, 10.1073/pnas.1901600116

Whiley, 2012, In-vial dual extraction for direct LC-MS analysis of plasma for comprehensive and highly reproducible metabolic fingerprinting, Anal Chem, 84, 5992, 10.1021/ac300716u

MacLean, 2010, Skyline: An open source document editor for creating and analyzing targeted proteomics experiments, Bioinformatics, 26, 966, 10.1093/bioinformatics/btq054

Peng, 2016, Adaptation of skyline for targeted lipidomics, J Proteome Res, 15, 291, 10.1021/acs.jproteome.5b00841

Sugasini, 2020, Plasma BDNF is a more reliable biomarker than erythrocyte omega-3 index for the omega-3 fatty acid enrichment of brain, Sci Rep, 10, 1, 10.1038/s41598-020-67868-9

Sugasini, 2017, Dietary docosahexaenoic acid (DHA) as lysophosphatidylcholine, but not as free acid, enriches brain DHA and improves memory in adult mice, Sci Rep, 7, 1, 10.1038/s41598-017-11766-0

Sugasini, 2019, Enrichment of brain docosahexaenoic acid (DHA) is highly dependent upon the molecular carrier of dietary DHA: Lysophosphatidylcholine is more efficient than either phosphatidylcholine or triacylglycerol, J Nutr Biochem, 74, 108231, 10.1016/j.jnutbio.2019.108231

Carboni, 2019, Mussel consumption as a “Food First” approach to improve omega-3 status, Nutrients, 11, 1381, 10.3390/nu11061381

Desikan, 2006, An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest, Neuroimage, 31, 968, 10.1016/j.neuroimage.2006.01.021

Elwood, 1995, The California verbal learning test: Psychometric characteristics and clinical application, Neuropsychol Rev, 5, 173, 10.1007/BF02214761

Tu, 2017, Egocentric versus allocentric spatial memory in behavioral variant frontotemporal dementia and Alzheimer’s disease, J Alzheimer’s Dis, 59, 883, 10.3233/JAD-160592

Coughlan, 2020, Functional connectivity between the entorhinal and posterior cingulate cortices underpins navigation discrepancies in at-risk Alzheimer’s disease, Neurobiol Aging, 90, 110, 10.1016/j.neurobiolaging.2020.02.007

Shine, 2019, Evidence for allocentric boundary and goal direction information in the human entorhinal cortex and subiculum, Nat Commun, 10, 1, 10.1038/s41467-019-11802-9

Tan, 2012, Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging, Neurology, 78, 658, 10.1212/WNL.0b013e318249f6a9

Zhang, 2017, Effects of DHA supplementation on hippocampal volume and cognitive function in older adults with mild cognitive impairment: A 12-month randomized, double-blind, placebo-controlled trial, J Alzheimer’s Dis, 55, 497, 10.3233/JAD-160439

Barberger-Gateau, 2007, Dietary patterns and risk of dementia: The three-city cohort study, Neurology, 69, 1921, 10.1212/01.wnl.0000278116.37320.52

Whalley, 2008, n-3 Fatty acid erythrocyte membrane content, APOE ε4, and cognitive variation: An observational follow-up study in late adulthood, Am J Clin Nutr, 87, 449, 10.1093/ajcn/87.2.449

Daiello, 2015, Association of fish oil supplement use with preservation of brain volume and cognitive function, Alzheimer’s Dement, 11, 226, 10.1016/j.jalz.2014.02.005

Etienne, 2004, Path integration in mammals, Hippocampus, 14, 180, 10.1002/hipo.10173

Howett, 2019, Differentiation of mild cognitive impairment using an entorhinal cortex-based test of virtual reality navigation, Brain, 142, 1751, 10.1093/brain/awz116

Banino, 2018, Vector-based navigation using grid-like representations in artificial agents, Nature, 557, 429, 10.1038/s41586-018-0102-6

Hasselmo, 2008, Grid cell mechanisms and function: Contributions of entorhinal persistent spiking and phase resetting, Hippocampus, 18, 1213, 10.1002/hipo.20512

Yassine, 2017, DHA brain uptake and APOE4 status: A PET study with [1-11C]-DHA, Alzheimers Res Ther, 9, 23, 10.1186/s13195-017-0250-1

Gungor, 2012, Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk, Atherosclerosis, 223, 230, 10.1016/j.atherosclerosis.2012.04.021

Weichselbaum, 2013, Fish in the diet: A review, Nutr Bull, 38, 128, 10.1111/nbu.12021

Henderson, 1995, Apolipoprotein E allele ∈4, dementia, and cognitive decline in a population sample, Lancet, 346, 1387, 10.1016/S0140-6736(95)92405-1

Stanciu, 2019, Efficacy and safety of alisporivir for the treatment of hepatitis C infection, Expert Opin Pharmacother, 20, 379, 10.1080/14656566.2018.1560424

Arellanes, 2020, Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial, EBioMedicine, 59, 102883, 10.1016/j.ebiom.2020.102883

Lane-Donovan, 2020, More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration, Neuron, 83, 771, 10.1016/j.neuron.2014.08.005